DU Tom 杜涛

Dr. Tom Du

  • Chairman, Evergreen Therapeutics, Inc

Founder and Chairman of Shenzhen Evergreen Pharmaceutical Co., Ltd.
• National Distinguished Expert; Visiting Professor of Peking Union Medical College
• Post-doctorate at Harvard Medical School; Ph.D. in Pathology, McGill University, Canada
• Former Founder/CEO of HPC Medical Consulting Co., Ltd. (HPC was acquired in 2019)
• Served as chief representative of UnitedHealthcare Group in China, director of clinical registration department
• Former Senior Director of Clinical and Registration Department of Hong Kong Hutchison Whampoa Pharmaceutical Company
• Former US FDA senior review officer (7 years)
• Served as a sharing investment partner, Piper Sandler, Morgan Stanley expert consultant
• Same as the third chairman of the Xinyi Talent Club (starting in July 2023); the former chairman of the FDA Expert Association; the designate chairman of the International Regulatory Committee of PhIRDA